Wholesale xce Tirzepatide Peptide Powder 5mg 10mg with 99.9% Content | Customizable for Research

We specialize in factory production, wholesale, and custom supply of xce tirzepatide raw powder, a high - purity (99.9%) pharmacy - grade peptide ideal for research use (not for personal use). xce tirzepatide (CAS No. 2023788 - 19 - 2, molecular formula C225H348N48O68) is a dual glucose - dependent insulinotropic polypeptide (GIP) and glucagon - like peptide - 1 (GLP - 1) receptor agonist, primarily studied for type 2 diabetes and weight management research.

The appearance of xce tirzepatide is a white powder, packaged as 10mg/vial with 10 vials per box, ensuring high quality and stability for research applications. With a molecular weight of 4813, xce tirzepatide exhibits enhanced water solubility due to PEG modification on the lys side chain, mimicking natural GIP actions at GIP receptors while also acting on GLP - 1 receptors.

In research contexts, xce tirzepatide has shown promising results in glucose control and weight loss studies. For instance, clinical trials like SURMOUNT - 1 reported average weight loss of 15% (5mg dose), 19.5% (10mg dose), and 20.9% (15mg dose) over 72 weeks, demonstrating its potential as a dual agonist for metabolic research. It is also being investigated for obesity - related health condition studies, with FDA Fast Track designation for obesity treatment research.

Storage of xce tirzepatide requires adherence to strict guidelines: store in a cold, dry, dark place; avoid repeated freezing/thawing, overexposure to air, light, or long - term solution storage; aliquot according to experimental needs. These practices preserve the peptide’s integrity for accurate research outcomes.

As a factory, we offer wholesale quantities and custom synthesis options for xce tirzepatide, catering to research institutions’ diverse needs. Our product meets pharmacy - grade standards, with a minimum order quantity (MOQ) of 10 vials, ensuring reliable supply for scientific investigations into diabetes, obesity, and metabolic disorders.

Note: xce tirzepatide is provided for research use only and not intended for personal or therapeutic use. Its dual GIP/GLP - 1 agonist mechanism makes it a valuable tool for studying novel treatments in type 2 diabetes and weight management, with a sequence similar to semaglutide but enhanced by PEG - modified lys for improved solubility and efficacy in preclinical and clinical research settings.